Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Zheng

Showing results (21-30 of 1,378) with videos related to

Pageof 138
Sort By:
Frontiers in Immunology|June 20, 2022
Dose-Dependent Effect of Tumor Mutation Burden on Cancer Prognosis Following Immune Checkpoint Blockade: Causal ImplicationsMing Zheng
Journal for Immunotherapy of Cancer|March 8, 2023
Systemic inflammation shapes clinical outcomes in response to immune checkpoint blockade treatment: moving toward optimizing antitumor immunityMing Zheng
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 29, 2024
Disease-wide association study uncovers disease continuum network of unipolar depressionMing Zheng
Colloids and Surfaces. B, Biointerfaces|September 15, 2024
Pathogen-associated geometric patternsMing Zheng
Autoimmunity Reviews|July 16, 2023
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprintingMing Zheng
Viruses|March 28, 2026
Beyond Pandemic Preparedness: Reframing Protracted War Against Infectious DiseasesMing Zheng
Frontiers in Immunology|November 15, 2021
The Gradient of Immune/Inflammatory Response and COVID-19 Prognosis with Therapeutic ImplicationsMing Zheng
Journal for Immunotherapy of Cancer|February 1, 2022
Tumor mutation burden for predicting immune checkpoint blockade response: the more, the betterMing Zheng
Journal for Immunotherapy of Cancer|January 5, 2023
Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockadeMing Zheng
Frontiers of Medicine|April 21, 2025
An expanded view of disease continuum centered on rheumatoid arthritis: from single to systemic perspectivesMing Zheng
Pageof 138

Showing results (21-30 of 1,378) with videos related to

Sort By:
Pageof 138
Frontiers in Immunology|June 20, 2022
Dose-Dependent Effect of Tumor Mutation Burden on Cancer Prognosis Following Immune Checkpoint Blockade: Causal ImplicationsMing Zheng
Journal for Immunotherapy of Cancer|March 8, 2023
Systemic inflammation shapes clinical outcomes in response to immune checkpoint blockade treatment: moving toward optimizing antitumor immunityMing Zheng
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 29, 2024
Disease-wide association study uncovers disease continuum network of unipolar depressionMing Zheng
Colloids and Surfaces. B, Biointerfaces|September 15, 2024
Pathogen-associated geometric patternsMing Zheng
Autoimmunity Reviews|July 16, 2023
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprintingMing Zheng
Viruses|March 28, 2026
Beyond Pandemic Preparedness: Reframing Protracted War Against Infectious DiseasesMing Zheng
Frontiers in Immunology|November 15, 2021
The Gradient of Immune/Inflammatory Response and COVID-19 Prognosis with Therapeutic ImplicationsMing Zheng
Journal for Immunotherapy of Cancer|February 1, 2022
Tumor mutation burden for predicting immune checkpoint blockade response: the more, the betterMing Zheng
Journal for Immunotherapy of Cancer|January 5, 2023
Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockadeMing Zheng
Frontiers of Medicine|April 21, 2025
An expanded view of disease continuum centered on rheumatoid arthritis: from single to systemic perspectivesMing Zheng
Pageof 138